NCT00460148View on ClinicalTrials.gov

Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 30, 2007

Study Completion Date

August 31, 2007

Conditions
Parkinson Disease
Interventions
DRUG

Ropinirole

Trial Locations (2)

6529

GSK Investigational Site, George

10117

GSK Investigational Site, Berlin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY